Accessibility Menu
 
Nanobiotix logo

Nanobiotix

(NASDAQ) NBTX

Current Price$34.35
Market Cap$1.49B
Since IPO (2020)+82%
5 Year+97%
1 Year+762%
1 Month-1%

Nanobiotix Financials at a Glance

Market Cap

$1.49B

Revenue (TTM)

$47.94M

Net Income (TTM)

$85.12M

EPS (TTM)

$0.00

P/E Ratio

-38.73

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$34.35

Volume

740

Open

$33.78

Previous Close

$34.35

Daily Range

$33.18 - $34.81

52-Week Range

$2.99 - $41.89

NBTX: Motley Fool Moneyball Superscore

60

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nanobiotix

Industry

Biotechnology

Employees

108

CEO

Laurent Lévy, PhD

Headquarters

Paris, 75012, FR

NBTX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-8%

Net Income Margin

-9%

Return on Equity

0%

Return on Capital

2%

Return on Assets

-1%

Earnings Yield

-2.58%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.49B

Shares Outstanding

48.38M

Volume

740

Short Interest

0.00%

Avg. Volume

45.00K

Financials (TTM)

Gross Profit

$11.61M

Operating Income

$68.39M

EBITDA

$58.32M

Operating Cash Flow

$19.55M

Capital Expenditure

$848.00K

Free Cash Flow

$20.40M

Cash & ST Invst.

$49.74M

Total Debt

$50.90M

Nanobiotix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$26.64M

+708.9%

Gross Profit

$26.64M

+708.9%

Gross Margin

100.00%

N/A

Market Cap

$1.49B

N/A

Market Cap/Employee

$13.83M

N/A

Employees

108

N/A

Net Income

$5.38M

+80.8%

EBITDA

$1.09M

+104.4%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$22.42M

+30.7%

Accounts Receivable

$1.84M

-35.2%

Inventory

$0.00

-100.0%

Long Term Debt

$46.51M

+5.6%

Short Term Debt

$4.74M

-52.5%

Return on Assets

-1.14%

N/A

Return on Invested Capital

2.46%

N/A

Free Cash Flow

$17.56M

+1.9%

Operating Cash Flow

$17.41M

+0.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SVRASavara Inc.
$5.58+2.20%
EYPTEyePoint Pharmaceuticals, Inc.
$13.02+1.01%
TYRATyra Biosciences, Inc.
$38.28-0.05%
GHRSGH Research PLC
$14.72+4.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%

Questions About NBTX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.